SC 13D/A

ARCH VENTURE FUND XII, L.P. - NEUMORA THERAPEUTICS -- SCH 13D/A(#2)

Company: Neumora Therapeutics, Inc.
Filed: November 22, 2024
Accession Number: 0001072613-24-000899

View Document ↗ View on SEC.gov ↗